Precision BioSciences: Q2 Earnings Snapshot

August 8, 2022 GMT

DURHAM, N.C. (AP) _ Precision BioSciences Inc. (DTIL) on Monday reported a second-quarter loss of $31 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 46 cents. Losses, adjusted for non-recurring costs, were 44 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.

The genome editing company posted revenue of $3.8 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $5 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on DTIL at